Advertisement
Person › Details
Thomas Strüngmann (STRÜNGMANN Group (family Strüngmann))
Strüngmann, Thomas (Hexal founder + Biotech investor)
Organisation | STRÜNGMANN Group (family Strüngmann) | |
Former/major organisation | Hexal AG | |
Group | Novartis (Group) | |
Record changed: 2021-07-27 |
Advertisement
More documents for Thomas Strüngmann
- [1] AC Immune S.A.. (7/27/21). "Press Release: AC Immune Announces Strategic Acquisition of Industry-leading Parkinson’s Disease Vaccine Candidate and Equity Investment Led by Athos Service GmbH". Lausanne....
- [2] AiCuris Anti-infective Cures GmbH. (2/23/18). "Press Release: AiCuris’ Licensee MSD Launches Prevymis (letermovir) in Germany". Wuppertal....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top